Use of this site is subject to, and your continued use constitutes your express agreement to be
bound by, the
Terms of Use and
Privacy Statement.
Any unauthorized use of this site is strictly prohibited.

XBRL Voluntary Filing Program
Visit the CSA’s XBRL website for information about XBRL and the voluntary program.Click here for information about XBRL software and viewing XBRL financial statements.

Medicenna Therapeutics Inc.

Mailing Address:

439 Helmcken StreetVancouver, British ColumbiaV6B2E6

Head Office Address:

439 Helmcken StreetVancouver, British ColumbiaV6B2E6

Contact Name:

Fahar Merchant

Principal Regulator:

Non-Reporting Issuer

Business e-mail address:

fmerchant@medicenna.com

Short Form Prospectus Issuer:

No

Telephone Number:

Reporting Jurisdictions:

Non-Reporting Issuer

Fax Number:

Stock Exchange:

N/A

Date of Formation:

Oct 31 2011

Stock Symbol:

Jurisdiction Where Formed:

British Columbai

Auditor:

Not Applicable

Industry Classification:

other

General Partner:

CUSIP Number:

58464V

Transfer Agent:

TMX Equity Transfer Services Inc.

Financial Year-End:

Dec 31

Size of Issuer (Assets):

$5,000,001 to $25,000,000

Use of this site is subject to, and your continued use constitutes your express agreement to be
bound by, the
Terms of Use and
Privacy Statement.
Any unauthorized use of this site is strictly prohibited.

XBRL Voluntary Filing Program
Visit the CSA’s XBRL website for information about XBRL and the voluntary program.Click here for information about XBRL software and viewing XBRL financial statements.